“…Based on the network pharmacology analysis, a total of 17 active components of SGN were screened out, and the drug-component-target network model was constructed; the key active components were mainly isofraxidin, astilbin, and rosmarinic, caffeic, neochlorogenic, and chlorogenic acid. Previous studies have demonstrated that rosmarinic acid and astilbin exhibit various pharmacological activities, such as anti-inflammatory ( Chu et al, 2012 ), hepatoprotective ( Guo et al, 2020 ), and anti-oxidative activities ( Sharma et al, 2020 ; Wang et al, 2020 ). Phenolic compounds, including neochlorogenic, chlorogenic, cryptochlorogenic, and caffeic acid, can treat metabolic syndrome since they exert anti-oxidative, anti-inflammatory, and antilipidemic effects ( Banjari et al, 2017 ; Santana-Galvez et al, 2017 ; Zhao et al, 2020 ).…”